TY - JOUR
T1 - Hepatic encephalopathy as a result of ammonia-induced increase in GABAergic tone with secondary reduced brain energy metabolism
AU - Sørensen, Michael
AU - Andersen, Jens Velde
AU - Bjerring, Peter Nissen
AU - Vilstrup, Hendrik
N1 - © 2024. The Author(s).
PY - 2024/11/19
Y1 - 2024/11/19
N2 - Hepatic encephalopathy (HE) is a neuropsychiatric syndrome caused by liver insufficiency and/or portosystemic shunting. HE is mostly episodic and as such reversible. Hyperammonemia clearly plays a key role in the pathophysiology, but the precise detrimental events in the brain leading to HE remain equivocal. Several pathogenic models have been proposed, but few have been linked to clinical studies and observations. Decreased oxygen metabolism is observed in both type A and C HE and in this review, we advocate that this reflects an actual reduced oxygen demand and not a primary cause of HE. As driving force, we propose that the hyperammonemia via astrocytic glutamine synthetase causes an increased γ-aminobutyric acid (GABA) mediated neuro-inhibition which subsequently leads to an overall decreased energy demand of the brain, something that can be enhanced by concomitant neuroinflammation. This also explains the reversibility of the condition.
AB - Hepatic encephalopathy (HE) is a neuropsychiatric syndrome caused by liver insufficiency and/or portosystemic shunting. HE is mostly episodic and as such reversible. Hyperammonemia clearly plays a key role in the pathophysiology, but the precise detrimental events in the brain leading to HE remain equivocal. Several pathogenic models have been proposed, but few have been linked to clinical studies and observations. Decreased oxygen metabolism is observed in both type A and C HE and in this review, we advocate that this reflects an actual reduced oxygen demand and not a primary cause of HE. As driving force, we propose that the hyperammonemia via astrocytic glutamine synthetase causes an increased γ-aminobutyric acid (GABA) mediated neuro-inhibition which subsequently leads to an overall decreased energy demand of the brain, something that can be enhanced by concomitant neuroinflammation. This also explains the reversibility of the condition.
KW - Hepatic Encephalopathy/metabolism
KW - Humans
KW - Energy Metabolism/drug effects
KW - Ammonia/metabolism
KW - Brain/metabolism
KW - Animals
KW - gamma-Aminobutyric Acid/metabolism
KW - Hyperammonemia/metabolism
KW - Astrocytes/metabolism
UR - http://www.scopus.com/inward/record.url?scp=85209390646&partnerID=8YFLogxK
U2 - 10.1007/s11011-024-01473-x
DO - 10.1007/s11011-024-01473-x
M3 - Review
C2 - 39560844
SN - 0885-7490
VL - 40
SP - 19
JO - Metabolic Brain Disease
JF - Metabolic Brain Disease
IS - 1
M1 - 19
ER -